Neuroprotective effects of chronic estradiol benzoate treatment on hippocampal cell loss induced by status epilepticus in the female rat

Neuroscience Letters

Volumn 281, Issue 2-3, 2000, Pages 79-82

  Reibel, Sophie ^a   André, Véronique ^a   Chassagnon, Serge ^a   André, Gabriel ^a   Marescaux, Christian ^a   Nehlig, Astrid ^a   Depaulis, Antoine ^a  

^a INSERM   (France)

Author keywords

Epilepsy; Estradiol benzoate; Hippocampus; Kainic acid; Neuroprotection; Status epilepticus

Indexed keywords

ESTRADIOL BENZOATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ELECTROENCEPHALOGRAPHY; EPILEPTIC STATE; FEMALE; HIPPOCAMPUS; NERVE CELL; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; RAT; SEIZURE;

ANIMALS; ESTRADIOL; EXCITATORY AMINO ACID AGONISTS; FEMALE; HIPPOCAMPUS; KAINIC ACID; NEUROPROTECTIVE AGENTS; OVARIECTOMY; RATS; RATS, SPRAGUE-DAWLEY; STATUS EPILEPTICUS;

EID: 0034003210     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(00)00784-9     Document Type: Article

References (32)

1. Azcoitia I., Sierra A., GarciaSegura L.M. Estradiol prevents kainic acid-induced neuronal loss in the rat dentate gyrus. NeuroReport. 9:1998;3075-3079.
2. Baldereschi M., DiCarlo A., Lepore V., Bracco L., Maggi S., Grigoletto F., Scarlato C., Amaducci L. Estrogen-replacement therapy and Alzheimer's disease in the Italian longitudinal study on aging. Neurology. 50:1998;996-1002.
3. Bishop J., Simpkins J.W. Role of estrogens in peripheral and cerebral glucose utilization. Rev. Neurosci. 3:1992;121-137.
4. Gibbs R.B. Levels of trkA and BDNF mRNA, but not NGF mRNA, fluctuate across the estrous cycle and increase in response to acute hormone replacement. Brain Res. 787:1998;259-268.
5. Goodman Y.D., Bruce A.J., Cheng B., Mattson M.P. Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid beta-peptide toxicity in hippocampal neurons. J. Neurochem. 66:1996;1836-1844.
6. Jagust W.J., Eberling J.L., Reed B.R., Mathis C.A., Budinger T.F. Clinical studies of cerebral blood flow in Alzheimer's disease. Ann. N.Y. Acad. Sci. 826:1997;254-262.
7. Kawas C., Resnick S., Morrison A., Brookmeyer R., Corrada M., Zonderman A., Bacal C., Lingle D.D., Metter E. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore longitudinal study of aging. Neurology. 48:1997;1517-1521.
8. Kondo Y., Suzuki K., Sakuma Y. Estrogen alleviates cognitive dysfunction following transient brain ischemia in ovariectomized gerbils. Neurosci. Lett. 238:1998;45-48.
9. Korte M., Carroll P., Wolf E., Brem G., Thoenen H., Bonhoeffer T. Hippocampal long-term potentiation is impaired in mice lacking brain-derived neurotrophic factor. Proc. Natl. Acad. Sci. USA. 92:1995;8856-8860.
10. Lundberg P.O. Catamenial epilepsy: a review. Cephalalgia. 17:1997;42-45.
11. Martin L.J., Al-Abdulla N.A., Brambrink A.M., Kirsch J.R., Sieber F.E., Portera-Cailliau C. Neurodegeneration in excitotoxicity, global cerebral ischemia, and target deprivation: a perspective on the contributions of apoptosis and necrosis. Brain Res. Bull. 46:1998;281-309.
12. Meldrum B. Excitotoxicity and epileptic brain damage. Epilepsy Res. 10:1991;55-61.
13. Multhaup G., Ruppert T., Schlicksupp A., Hesse L., Beher D., Masters C.L., Beyreuther K. Reactive oxygen species and Alzheimer's disease. Biochem. Pharmacol. 54:1997;533-539.
14. Nicoletti F., Speciale C., Sortino M.A., Summa G., Caruso G., Patti F., Canonico P.L. Comparative effects of estradiol benzoate, the antiestrogen clomiphen citrate, and the progestin medroxyprogesterone acetate on kainic acid-induced seizures in male and female rats. Epilepsia. 26:1985;252-257.
15. Paganini-Hill A. Estrogen replacement therapy and stroke. Prog. Cardiovasc. Dis. 38:1995;223-242.
16. Paganini-Hill A., Henderson V.W. Estrogen deficiency and risk of Alzheimer's disease in women. Am. J. Epidemiol. 140:1994;256-261.
17. Panickar K.S., Guan G.W., King M.A., Rajakumar G., Simpkins J.W. 17 beta-estradiol attenuates CREB decline in the rat hippocampus following seizure. J. Neurobiol. 33:1997;961-967.
18. Parent J.M., Yu T.W., Leibowitz R.T., Geschwind D.H., Sloviter R.S., Lowenstein D.H. Dentate granule cell neurogenesis is increased by seizures and contributes to aberrant network reorganization in the adult rat hippocampus. J. Neurosci. 17:1997;3737-3738.
19. Paxinos G., Watson C. The Rat Brain in Stereotaxic Co-ordinates. 2nd edn. 1986;Academic Press, San Diego CA
20. Peters O., Back T., Lindauer U., Busch C., Megow D., Dreier J., Dirnagl U. Increased formation of reactive oxygen species after permanent and reversible middle cerebral artery occlusion in the rat. J. Cereb. Blood Flow Metab. 18:1998;196-205.
21. Pike C.J. Estrogen modulates neuronal Bcl-xL expression and beta-amyloid-induced apoptosis: relevance to Alzheimer's disease. J. Neurochem. 72:1999;1552-1563.
22. Pollard H., Charriaut-Marlangue C., Cantagrel S., Represa A., Robain O., Moreau J., Ben-Ari Y. Kainate-induced apoptotic cell death in hippocampal neurons. Neuroscience. 63:1994;7-18.
23. Rusa R., Alkayed N.J., Crain B.J., Traystman R.J., Kimes A.S., London E.D., Klaus J.A., Hurn P.D. 17 beta-estradiol reduces stroke injury in estrogen-deficient female animals. Stroke. 30:1999;1665-1670.
24. Simpkins J.W., Rabbani O., Shi J., Panickar K.S., Green P.S., Day A.L. A system for the brain enhanced delivery of estradiol: an assessment of its potential for the treatment of Alzheimer's disease and stroke. Pharmazie. 53:1998;505-511.
25. Simpkins J.W., Rajakamar G., Zhang Y.Q., Simpkins C.E., Greenwald D., Yu C.J., Bodor N., Day A.L. Estrogens may reduce mortality and ischemic damage caused by middle cerebral artery occlusion in the female rat. J. Neurosurg. 87:1997;724-730.
26. Singer C.A., Rogers K.L., Dorsa D.M. Modulation of Bcl-2 expression: a potential component of estrogen protection in NT2 neurons. NeuroReport. 9:1998;2565-2568.
27. Singh M., Setalo G. Jr, Guan X., Warren M., Torand-Allerand C.D. Estrogen-induced activation of mitogen-activated protein kinase in cerebral cortical explants: convergence of estrogen and neurotrophin signaling pathways. J. Neurosci. 19:1999;1179-1188.
28. Sperk G. Kainic acid seizures in the rat. Prog. Neurobiol. 42:1994;1-32.
29. Sudo S., Wen T.C., Desaki J., Matsuda S., Tanaka J., Arai T., Maeda N., Sakanaka M. beta-Estradiol protects hippocampal CA1 neurons against transient forebrain ischemia in gerbils. Neurosci. Res. 29:1997;345-354.
30. Tanapat P., Hastings N.B., Reeves A.J., Gould E. Estrogen stimulates a transient increase in the number of new neurons in the dentate gyrus of the adult female rat. J. Neurosci. 19:1999;5792-5801.
31. Tang M.X., Jacobs D., Stern Y., Marder K., Schofield P., Gurland B., Andrews H., Mayeux R. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet. 348:1996;429-432.
32. Weaver C.E., ParkChung M., Gibbs T.T., Farb D.H. 17 beta-estradiol protects against NMDA-induced excitotoxicity by direct inhibition of NMDA receptors. Brain Res. 761:1997;338-341.